Skip to main content

Sulfur Conjugates as Putative Pneumotoxic Metabolites of the Pyrrolizidine Alkaloid, Monocrotaline

  • Chapter
Biological Reactive Intermediates IV

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 283))

Abstract

Well over 200 pyrrolizidine alkaloids are known, distributed in a number of plant families (Huxtable, 1989; Mattocks, 1986). Important pyrrolizidine-containing families include Crotalaria, Symphytum, Heliotropium and Senecio. Alkaloids containing a 1,2-double bond (Fig. 1) are hepatotoxic, producing veno-occlusive disease in experimental animals, livestock and humans. A relatively small number of alkaloids are also pneumotoxic, producing pulmonary arterial hypertension, arterial medial hyperplasia, endothelial proliferation, and right ventricular hypertrophy in selected species (Huxtable, 1990). Pneumotoxic alkaloids include the Crotalaria lkaloids, monocrotaline and fulvine, and the Senecio alkaloids, senecionine and seneciphylline. Pulmonary hyperplasia and right ventricular hypertrophy are produced in rats by monocrotaline following a single injection of 0.12–0.36 mmole/kg, or a total dose of 0.04 mmole/kg given subacutely (Shubat, Hubbard and Huxtable, 1989). However, pneumotoxicity is delayed in appearance. Following a single injection, pulmonary hyperplasia is first detectable after seven days, pulmonary arterial blood pressure is raised after nine days, and right ventricular hypertrophy develops after fourteen days. These effects are caused by hepatic metabolites of monocrotaline. Monocrotaline itself has no effect on the isolated, perfused lung, and lung tissue appears to be incapable of metabolizing the alkaloid (Gillis, Huxtable and Roth, 1978).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Bakke, J. and Gustafsson, J.-A. (1984). Mercapturic acid pathway metabolites of xenobiotics: generation of potentially toxic metabolites during enterohepatic circulation. TIPS 5, 517–521.

    CAS  Google Scholar 

  • Bruner, L.H., Hilliker, K.S. and Roth, R.A. (1983). Pulmonary hypertension and ECG changes from monocrotaline pyrrole in the rat. Am. J. Physiol. 245, H300 - H306.

    CAS  PubMed  Google Scholar 

  • Dekant, W., Lash, L.H. and Anders, M.W. (1988). Fate of glutathione conjugates and bioactivation of cysteine S-conjugates by cysteine conjugate beta-lyase. In Glutathione conjugation: Mechanisms and Biological Significance, edited by Sies, H. and Ketterer, B. pp. 415–447. Academic Press Limited, London.

    Google Scholar 

  • Gillis, C.N., Huxtable, R.J. and Roth, R.A. (1978). Effect of monocrotaline pretreatment of rats on removal of 5-hydroxytryptamine and norepinephrine by perfused lung. Brit. J. Pharmacol. 63, 435–443.

    CAS  Google Scholar 

  • Hsu, I.C., Allen, J.R. and Chesney, C.F. (1973). Identification and toxicological effects of dehydroretronecine, a metabolite of monocrotaline. Proc. Soc. Exp. Biol. Med. 144, 834–838.

    CAS  PubMed  Google Scholar 

  • Huxtable, R.J. (1989). Human health implications of pyrrolizidine alkaloids and herbs containing them. In Toxicants of Plant Origin, Vol I: Alkaloids edited by Cheeke, P.R. pp. 41–86. CRC Press, Boca Raton, FL.

    Google Scholar 

  • Huxtable, R.J. (1990). Activation and pulmonary toxicity of pyrrolizidine alkaloids. Pharmacology and Therapeutics,in press.

    Google Scholar 

  • Huxtable, R.J., Ciaramitaro, D. and Eisenstein, D. (1978). The effect of a pyrrolizidine alkaloid, monocrotaline, and a pyrrole, dehydroretronecine, on the biochemical functions of the pulmonary endothelium. Mol. Pharmacol. 14, 1189–1203.

    Google Scholar 

  • Kedzierski, B. and Buhler, D.R. (1986). The formation of 6,7-dihydro-7-hydroxy-lhydroxymethyl-5H-pyrrolizine, a metabolite of pyrrolizidine alkalods. ChemBiol. Inter. 57, 217–222.

    CAS  Google Scholar 

  • Lafranconi, W.M. and Huxtable, R.J. (1984). Hepatic metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung. Biochem. Pharm. 33, 2479–2484.

    Article  CAS  PubMed  Google Scholar 

  • Lafranconi, W.M., Ohkuma, S. and Huxtable, R.J. (1985). Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline. Toxicon 23, 983–992.

    Article  CAS  PubMed  Google Scholar 

  • Mattocks, A.R. (1968). Toxicity of pyrrolizidine alkaloids. Nature (London) 217, 723–728.

    Article  CAS  Google Scholar 

  • Mattocks, A.R. (1972). Acute hepatotoxicity and pyrrolic metabolites in rats dosed with pyrrolizidine alkaloids. Chem. -Biol. Interactions 5, 227–242.

    CAS  Google Scholar 

  • Mattocks, A.R. (1986). Chemistry and Toxicology of Pyrrolizidine Alkaloids, London: Academic Press, pp. 1–393.

    Google Scholar 

  • Mattocks, A.R. (1990). Pyrrolizidine alkaloids: what metabolites are responsible for extrahepatic tissue damage in animals? Proceedings of the Third International Symposium on Poisonous Plants, edited by James, L.F., in press.

    Google Scholar 

  • Mattocks, A.R., Jukes, R. and Brown, J. (1989). Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids. Toxicon 27, 561–567.

    Article  CAS  PubMed  Google Scholar 

  • Ramsdell, H.S., Kedzierski, B. and Buhler, D.R. (1987). Microsomal metabolism of pyrrolizidine alkaloids from Senecio jacobaea: isolation and quantification of 6,7dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine and N-oxides by high performance liquid chromatography. Drug Metab. Dispos. 15, 32–36.

    CAS  PubMed  Google Scholar 

  • Roth, R.A., Dotzlaf, L.A., Baranyi, B., Kuo, C.H. and Hook, J.B. (1981). Effect of monocrotaline ingestion on liver, kidney, and lung of rats. Toxicol. Appl. Pharmacol. 60, 193–203.

    Article  CAS  PubMed  Google Scholar 

  • Shubat, P.J., Hubbard, A.K. and Huxtable, R.J. (1989). Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline. J. Toxicol. Environ. Health 28, 445–460.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Plenum Press, New York

About this chapter

Cite this chapter

Huxtable, R.J., Bowers, R., Mattocks, A.R., Michnicka, M. (1991). Sulfur Conjugates as Putative Pneumotoxic Metabolites of the Pyrrolizidine Alkaloid, Monocrotaline. In: Witmer, C.M., Snyder, R.R., Jollow, D.J., Kalf, G.F., Kocsis, J.J., Sipes, I.G. (eds) Biological Reactive Intermediates IV. Advances in Experimental Medicine and Biology, vol 283. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5877-0_76

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5877-0_76

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5879-4

  • Online ISBN: 978-1-4684-5877-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics